Literature DB >> 19384292

Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR.

Fabrizia Urbinati1, Paritha Arumugam, Tomoyasu Higashimoto, Anil Perumbeti, Kyle Mitts, Ping Xia, Punam Malik.   

Abstract

Self-inactivating (SIN) lentiviruses flanked by the 1.2-kb chicken hypersensitive site-4 (cHS4) insulator element provide consistent, improved expression of transgenes, but have significantly lower titers. The mechanism by which this occurs is unknown. Lengthening the lentiviral (LV) vector transgene cassette by an additional 1.2 kb by an internal cassette caused no further reduction in titers. However, when cHS4 sequences or inert DNA spacers of increasing size were placed in the 3'-long terminal repeat (LTR), infectious titers decreased proportional to the length of the insert. The stage of vector life cycle affected by vectors carrying the large cHS4 3'LTR insert was compared to a control vector: there was no increase in read-through transcription with insertion of the 1.2-kb cHS4 in the 3'LTR. Equal amount of full-length viral mRNA was produced in packaging cells and viral assembly/packaging was unaffected, resulting in comparable amounts of intact vector particles produced by either vectors. However, LV vectors carrying cHS4 in the 3'LTR were inefficiently processed following target-cell entry, with reduced reverse transcription and integration efficiency, and hence lower transduction titers. Therefore, vectors with large insertions in the 3'LTR are transcribed and packaged efficiently, but the LTR insert hinders viral-RNA (vRNA) processing and transduction of target cells. These studies have important implications in design of integrating vectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384292      PMCID: PMC2835256          DOI: 10.1038/mt.2009.89

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  49 in total

1.  Integration complexes derived from HIV vectors for rapid assays in vitro.

Authors:  M S Hansen; G J Smith; T Kafri; V Molteni; J S Siegel; F D Bushman
Journal:  Nat Biotechnol       Date:  1999-06       Impact factor: 54.908

2.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Systematic determination of the packaging limit of lentiviral vectors.

Authors:  M Kumar; B Keller; N Makalou; R E Sutton
Journal:  Hum Gene Ther       Date:  2001-10-10       Impact factor: 5.695

4.  Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo.

Authors:  David W Emery; Evangelia Yannaki; Julie Tubb; Tamon Nishino; Qiliang Li; George Stamatoyannopoulos
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

5.  Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

Authors:  Jianling Zhuang; Amanda E Jetzt; Guoli Sun; Hong Yu; George Klarmann; Yacov Ron; Bradley D Preston; Joseph P Dougherty
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription.

Authors:  B Berkhout; N L Vastenhouw; B I Klasens; H Huthoff
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

7.  RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.

Authors:  Anne-Kathrin Zaiss; Sodany Son; Lung-Ji Chang
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.

Authors:  Suzan Imren; Emmanuel Payen; Karen A Westerman; Robert Pawliuk; Mary E Fabry; Connie J Eaves; Benjamin Cavilla; Louis D Wadsworth; Yves Beuzard; Eric E Bouhassira; Robert Russell; Irving M London; Ronald L Nagel; Philippe Leboulch; R Keith Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

9.  Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.

Authors:  Francesco Lotti; Emilio Menguzzato; Claudia Rossi; Luigi Naldini; Laurie Ailles; Fulvio Mavilio; Giuliana Ferrari
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors.

Authors:  F Moreau-Gaudry; P Xia; G Jiang; N P Perelman; G Bauer; J Ellis; K H Surinya; F Mavilio; C K Shen; P Malik
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

View more
  33 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

2.  A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.

Authors:  Fang Zhang; Amy R Frost; Mike P Blundell; Olivia Bales; Michael N Antoniou; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-06-29       Impact factor: 11.454

Review 3.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

4.  Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.

Authors:  Paritha I Arumugam; Tomoyasu Higashimoto; Fabrizia Urbinati; Ute Modlich; Shawna Nestheide; Ping Xia; Catherine Fox; Andrea Corsinotti; Christopher Baum; Punam Malik
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

Review 5.  The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.

Authors:  David W Emery
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

6.  Prototypic chromatin insulator cHS4 protects retroviral transgene from silencing in Schistosoma mansoni.

Authors:  Sutas Suttiprapa; Gabriel Rinaldi; Paul J Brindley
Journal:  Transgenic Res       Date:  2011-09-15       Impact factor: 2.788

Review 7.  Optimizing autologous cell grafts to improve stem cell gene therapy.

Authors:  Nikoletta Psatha; Garyfalia Karponi; Evangelia Yannaki
Journal:  Exp Hematol       Date:  2016-04-19       Impact factor: 3.084

8.  Cell cycle status of CD34(+) hemopoietic stem cells determines lentiviral integration in actively transcribed and development-related genes.

Authors:  Eleni Papanikolaou; Anna Paruzynski; Ioannis Kasampalidis; Annette Deichmann; Evangelos Stamateris; Manfred Schmidt; Christof von Kalle; Nicholas P Anagnou
Journal:  Mol Ther       Date:  2014-12-19       Impact factor: 11.454

9.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Maria Nascimento Primo; Camilla Darum Sørensen; Jacob Giehm Mikkelsen
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

10.  The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity.

Authors:  Paritha I Arumugam; Fabrizia Urbinati; Chinavenmeni S Velu; Tomoyasu Higashimoto; H Leighton Grimes; Punam Malik
Journal:  PLoS One       Date:  2009-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.